Actividades de contabilidad, teneduría de libros, auditoría y asesoría fiscal
Productos y servicios
PRESTACION DE SERVICIOS DE ADMINISTRACION, GESTION Y CONTROL A SUS SOCIEDADES DEPENDIENTES, DEL SECTOR MEDICO-FARMACEUTICO.
Actividades
Actividades de contabilidad, teneduría de libros, auditoría y asesoría fiscal
Actividades de las sociedades holding
Actividades de contabilidad, teneduría de libros, auditoría y asesoría fiscal
Actividades de las sociedades holding
Accounting, bookkeeping and auditing activities; tax consultancy
Activities of holding companies
This company is engaged in the research, development, manufacture and marketing of plasma derivatives, IV therapy, enteral nutrition, diagnostic systems and medical materials. Established in 1940, the company was formerly known as Probitas Pharma S.A. It has a registered office located in Barcelona, Spain. The company is structured in three divisions: bioscience, which specializes in the research, development, production and commercialization of plasma derivatives; diagnostic, which focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for hospital blood banks and transfusion centers; and hospital, which provides a wide range of non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. The company's products include Alphanate, AlphaNine, Profilnine SD, Albutein, Anbinex, Flebogamma, Igantet, Igamad, Trypsone, Soyacal, Vacuflasc, Misterium, PhaSeal, Fleboset, Griflow Dual, Accufuser, Leucored system, Triturus systems, Diana system and others. The company aims to assist professionals in securing the health and well-being of humanity through dedicated service and innovative products. It is a group of companies, which serves healthcare professionals and patients in more than 70 countries around the world, including in Italy, Argentina, Singapore, Brazil, Chile, Germany, the United States of America, Poland, the Czech Republic, Mexico, Ireland, Portugal, the United Kingdom, France and Malaysia.
